Skip to content Skip to main menu

Smart Healthcare

OUR MICROBIOME DETERMINES BALANCED HEALTH

MD Healthcare’s main strength is our unique microbiome extracellular vesicle (EV) convergence technology that has enabled us to secure over 40 international and domestic patents with over pending applications.

MDH-001

Key patent

·Extracellular Vesicles Derived from Lactobacillus paracasei and Use Thereof

·Composition for preventing or treating Nerve Disorder and Metal Disorder, containing Lactobacillus paracasei bacteria-derived vesicle

·Composition for regulating stem cell function comprising Extracellular Vesicles derived from bacteria of the Lactobacillus as an active ingredient

Defense patent

·Extracellular Vesicles Derived from Lactobacillus and Use Thereof

·Extracellular Vesicles Derived from Streptococcus and Use Thereof

·Extracellular Vesicles Derived from Bifidobacterium and Use Thereof

·Extracellular Vesicles Derived from Faecalibacterium prausnitzii and Use Thereof

·Extracellular Vesicles Derived from Weissella and Use Thereof

MDH-002

Key patent

·Composition for Prevention or Treatment of Inflammatory disease Comprising Extracellular Vesicles Derived from Lactic acid bacteria

·Composition for Prevention or Treatment of Mental Disorders Comprising Extracellular Vesicles Derived from Lactobacillus

MDH-003

Key patent

·Nanovesicles derived from Lactobacillus bacteria and Use thereof (Division: Rhamnosus)

MDH-009

Defense patent

·A composition for improving intestine function comprising genus Leuconostoc

·A composition for improving liver function comprising genus Leuconostoc

MDH-101

Key patent

·Nano-Vesicles Derived from Genus Micrococcus Bacteria and Use Thereof

Defense patent

·Nanovesicles derived from Geobacillus bacteria and Use thereof

·Nanovesicles derived from Deinococcus bacteria and Use thereof

·Nanovesicles derived from Rhodococcus bacteria and Use thereof

·Nanovesicles derived from Rothia bacteria and Use thereof

MDH-201, MDH-203

Key patent

·Nanovesicle Derived from Proteus Genus Bacteria, and Use Thereof (MDH-201)

·Nano-Vesicles Derived from Genus Cupriavidus Bacteria and Use Thereof (MDH-203)

Defense patent

·Nanovesicles derived from Rhizobium bacteria and Use thereof (Both)

·Nanovesicles derived from Enhydrobacter bacteria and Use thereof (Both)

·Nanovesicles derived from Acinetobacter bacteria and Use thereof (Both)

·Nanovesicles derived from Methylobacterium bacteria and Use thereof (Both)

·Nanovesicles derived from Pseudomonas bacteria and Use thereof (Both)

·Composition for enhancing sensitivity of anti-cancer drug (MDH-203)

MDH-204

Key patent

·Nanovesicles derived from Sphingomonas bacteria and Use thereof